Selective degradation of the p53‐R175H oncogenic hotspot mutant by an RNA aptamer‐based PROTAC
Clinical and Translational Medicine · 2023-02 · 13 (2)
DOI: 10.1002/ctm2.1191 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Translational Medicine, online erschienen am 29.01.2023. Verfasst von Lingping Kong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Aptamers, Nucleotide. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, China.
- Laboratory of Molecular Modeling and Design, State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.
- Center for Cell Structure and Function, Shandong Provincial Key Laboratory of Animal Resistance Biology, Collaborative Innovation Center of Cell Biology in Universities of Shandong, College of Life Sciences, Shandong No…
- Haihe Laboratory of Cell Ecosystem, Tianjin, China.
- State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China.
- School of Life Sciences and Medicine, Shandong University of Technology, Zibo, Shandong, China.
ORCID-Profile: Songbo Xie
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Kong, L., Meng, F., Wu, S., Zhou, P., Ge, R., Liu, M., Zhang, L., Zhou, J., Zhong, D., & Xie, S. (2023). Selective degradation of the p53‐R175H oncogenic hotspot mutant by an RNA aptamer‐based PROTAC. Clinical and Translational Medicine, 13(2). https://doi.org/10.1002/ctm2.1191
Vancouver
Kong L, Meng F, Wu S, Zhou P, Ge R, Liu M, et al. Selective degradation of the p53‐R175H oncogenic hotspot mutant by an RNA aptamer‐based PROTAC. Clinical and Translational Medicine. 2023;13(2). doi:10.1002/ctm2.1191
BibTeX
@article{Kong2023,
author = {Kong, Lingping and Meng, Fanlu and Wu, Sijin and Zhou, Ping and Ge, Ruixin and Liu, Min and Zhang, Linlin and Zhou, Jun and Zhong, Diansheng and Xie, Songbo},
title = {Selective degradation of the p53‐R175H oncogenic hotspot mutant by an RNA aptamer‐based PROTAC},
journal = {Clinical and Translational Medicine},
year = {2023},
volume = {13},
number = {2},
doi = {10.1002/ctm2.1191}
}
EUVIMED